0001354457-23-000652.txt : 20230908
0001354457-23-000652.hdr.sgml : 20230908
20230908101145
ACCESSION NUMBER: 0001354457-23-000652
CONFORMED SUBMISSION TYPE: 25-NSE
CONFIRMING COPY:
PUBLIC DOCUMENT COUNT: 2
FILED AS OF DATE: 20230908
DATE AS OF CHANGE: 20230908
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: 9 METERS BIOPHARMA, INC.
CENTRAL INDEX KEY: 0001551986
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 273948465
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 25-NSE
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37797
BUSINESS ADDRESS:
STREET 1: 4509 CREEDMOOR ROAD
STREET 2: SUITE 600
CITY: RALEIGH
STATE: NC
ZIP: 27612
BUSINESS PHONE: 919-275-1933
MAIL ADDRESS:
STREET 1: 4509 CREEDMOOR ROAD
STREET 2: SUITE 600
CITY: RALEIGH
STATE: NC
ZIP: 27612
FORMER COMPANY:
FORMER CONFORMED NAME: INNOVATE BIOPHARMACEUTICALS, INC.
DATE OF NAME CHANGE: 20180201
FORMER COMPANY:
FORMER CONFORMED NAME: Monster Digital, Inc.
DATE OF NAME CHANGE: 20150930
FORMER COMPANY:
FORMER CONFORMED NAME: Tandon Digital, Inc.
DATE OF NAME CHANGE: 20120611
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: Nasdaq Stock Market LLC
CENTRAL INDEX KEY: 0001354457
IRS NUMBER: 521165937
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 25-NSE
BUSINESS ADDRESS:
STREET 1: One Liberty Plaza
CITY: New York
STATE: NY
ZIP: 10006
BUSINESS PHONE: 301-978-4144
MAIL ADDRESS:
STREET 1: Office of General Counsel
STREET 2: 805 King Farm Blvd.
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
FORMER COMPANY:
FORMER CONFORMED NAME: The Nasdaq Stock Market LLC
DATE OF NAME CHANGE: 20060224
25-NSE
1
primary_doc.xml
X0203
0001354457
Nasdaq Stock Market LLC
0001551986
9 METERS BIOPHARMA, INC.
001-37797
8480 Honeycutt Road, Suite 120
Raleigh
NC
NORTH CAROLINA
27615
8059554190
Common stock
17 CFR 240.12d2-2(b)
Aravind Menon
Hearings Advisor
2023-09-08
EX-99.25
2
nmtrdelistreason.txt
Delisting Determination, The Nasdaq Stock Market, LLC, September 8, 2023,
9 Meters Biopharma, Inc.
The Nasdaq Stock Market LLC (the Exchange) has determined to remove
from listing the common stock of 9 Meters Biopharma, Inc. (the Company),
effective at the opening of the trading session on September 18, 2023.
Based on review of information provided by the Company, Nasdaq
Staff determined that the Company no longer qualified for listing
on the Exchange pursuant to Listing Rules 5101, 5110(b), and IM-5101-1.
The Company was notified of the Staff determination on
July 17, 2023. The Company did not appeal the Staff determination
to the Hearings Panel. The Company securities were suspended on
July 26, 2023. The Staff determination to delist the Company
securities became final on July 26, 2023.